Form 4: Privia Health Group Director Jaewon Ryu Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


Director Jaewon Ryu reports acquisition of restricted stock units and disposal of common stock in Privia Health Group, Inc.

Summary

  • On May 22, 2024, Jaewon Ryu, a director of Privia Health Group, Inc., reported transactions involving the company's stock.
  • Ryu acquired 11,124 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan.
  • The restricted stock units will vest on the earlier of (i) the day immediately preceding the Company's 2025 annual meeting of stockholders and (ii) the first anniversary of the date of the grant.
  • Ryu also disposed of 30,251 shares of common stock.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting stock transactions by a company director, indicating a neutral sentiment.

Future Outlook

The restricted stock units will vest on the earlier of (i) the day immediately preceding the Company's 2025 annual meeting of stockholders and (ii) the first anniversary of the date of the grant.

Industry Context

This filing is a routine disclosure of stock transactions by a company insider, which is common practice for publicly traded companies.

Stakeholder Impact

  • The acquisition of restricted stock units by a director could be seen as a positive sign by shareholders, aligning management's interests with theirs.
  • The disposal of common stock by a director could be seen as a negative sign by shareholders.

Key Dates

DateDescription
05/22/2024Date of transaction: acquisition of 11,124 restricted stock units and disposal of 30,251 shares of common stock.
05/23/2024Date of signature on the report.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.